Cefaclor CAS 53994-73-3: Your Trusted Pharmaceutical Intermediate
Discover the high-purity Cefaclor, essential for treating diverse bacterial infections effectively and safely.
Get a Quote & SampleProduct Core Value

Cefaclor
Cefaclor, a second-generation cephalosporin antibiotic, is a vital pharmaceutical intermediate. With a purity of ≥99.5%MIN and adherence to USP, BP, EP, and FCC standards, it is a reliable choice for manufacturing medications. Its efficacy in treating bacterial infections of the ear, skin, urine, lung, and throat makes it indispensable in the pharmaceutical industry.
- Leverage the power of Cefaclor for effective bacterial infections treatment, ensuring optimal patient outcomes.
- Discover the Cefaclor pharmaceutical intermediate, crucial for your API synthesis needs.
- Ensure product quality with Cefaclor meeting USP, BP, EP, and FCC standards.
- Explore the comprehensive uses of Cefaclor in treating various bacterial infections, including respiratory tract infections.
Product Advantages
Uncompromised Purity
Achieve superior results with Cefaclor's high purity of 99.5%MIN, ensuring the efficacy of your finished pharmaceutical products.
Global Standards Compliance
Gain confidence with Cefaclor that meets stringent USP, BP, EP, and FCC standards, simplifying regulatory compliance.
Broad-Spectrum Efficacy
Address a wide range of bacterial infections, from ear infections to pneumonia, with the proven effectiveness of Cefaclor.
Key Applications
Pharmaceutical Manufacturing
As a key pharmaceutical intermediate, Cefaclor is essential for the synthesis of various antibiotic drugs, supporting effective bacterial infections treatment.
Respiratory Tract Infections
Cefaclor plays a critical role in combating respiratory tract infections, contributing to improved patient health and recovery.
Urinary Tract Infections
Utilize Cefaclor for the reliable treatment of urinary tract infections, a common and often debilitating condition.
Skin and Soft Tissue Infections
Cefaclor is instrumental in treating various skin and soft tissue infections, a significant area of medical need.